Alternatives to PhaseV
PhaseV is a Life Sciences tool: develops a platform for adaptive clinical trial design and closed-loop execution. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Life Sciences companies to PhaseV
Mana.bioNot ratedAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
QuantHealthNot ratedAI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Upstream BioNot ratedClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
ProtaiNot ratedAI-driven platform for protein-level disease mapping and drug discovery.
- COCombinable.aiNot rated
Omnix MedicalNot ratedOmnix Medical is developing a novel platform for advanced wound care management.
EximoreNot ratedBiopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
ZipBioNot ratedCompressing biology to develop the next generation of therapies.
POLARISqbNot ratedRevolutionizing drug design using quantum computing, AI, and personalized medicine.
Gamida CellNot ratedBiotechnology company developing potentially curative cell therapies for cancer patients.
Nectin TherapeuticsNot ratedBiotech company developing next-generation immunotherapy agents to unlock the immune system.
ImmunaiNot ratedMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
IdentifAI GeneticsNot ratedRevolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.
Prism AINot ratedAI platform for discovering complex multi-omics signatures for personalized medicine.
Code OceanNot ratedCloud-based platform for reproducible computational research in life sciences.
Genocure AINot ratedGenocure AI is developing AI-powered solutions for oncology drug discovery and development.
SmartOmicaNot ratedEU-based company providing personalized medicine solutions for medical practitioners.
- AYAyala PharmaceuticalsNot rated
Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.
Impact BiotechNot ratedDevelops and launches Padeliporfin VTP therapy for solid tumor treatment.
QurisNot ratedAI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.
Showing the next 20 closest matches. See the rest on the PhaseV profile.
Sponsored rows are paid and labelled. Advertise on this page

